John P. Perentesis

6.3k total citations · 3 hit papers
140 papers, 4.1k citations indexed

About

John P. Perentesis is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John P. Perentesis has authored 140 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 43 papers in Hematology and 38 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John P. Perentesis's work include Acute Lymphoblastic Leukemia research (36 papers), Acute Myeloid Leukemia Research (32 papers) and Neuroblastoma Research and Treatments (28 papers). John P. Perentesis is often cited by papers focused on Acute Lymphoblastic Leukemia research (36 papers), Acute Myeloid Leukemia Research (32 papers) and Neuroblastoma Research and Treatments (28 papers). John P. Perentesis collaborates with scholars based in United States, Canada and Switzerland. John P. Perentesis's co-authors include Stella M. Davies, Julie A. Ross, Leslie L. Robison, Todd A. Alonzo, Anthony Mascia, Mathieu Sertorio, Ricky A. Sharma, Robert B. Gerbing, James W. Bodley and Gretchen A. Radloff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

John P. Perentesis

135 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

2022 297 citations Anthony Mascia, Emily Daugherty et al. profile →
FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice

2021 162 citations Swati Girdhani, Ricky A. Sharma et al. profile →
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach

2024 47 citations Emily Daugherty, Zhiyan Xiao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John P. Perentesis United States	39	1.4k	1.3k	818	764	707	140	4.1k
John N. Lukens United States	39	1.9k 1.3×	949 0.7×	1000 1.2×	911 1.2×	2.6k 3.7×	204	7.1k
Bronno van der Holt Netherlands	51	2.1k 1.5×	966 0.8×	647 0.8×	3.1k 4.1×	784 1.1×	224	7.8k
Gloria Broadwater United States	42	1.2k 0.8×	1.0k 0.8×	286 0.3×	530 0.7×	135 0.2×	182	6.2k
Jeremy Millar Australia	37	553 0.4×	3.8k 3.0×	326 0.4×	401 0.5×	188 0.3×	294	6.5k
Michael Crump Canada	49	1.6k 1.1×	1.4k 1.1×	672 0.8×	1.0k 1.3×	1.5k 2.1×	310	9.8k
Samuel Hellmän United States	57	1.4k 1.0×	3.0k 2.4×	370 0.5×	752 1.0×	508 0.7×	238	10.8k
Xuemei Wang United States	54	2.1k 1.5×	3.1k 2.4×	1.1k 1.4×	2.8k 3.7×	279 0.4×	252	10.4k
Linda Mileshkin Australia	40	1.6k 1.1×	938 0.7×	411 0.5×	502 0.7×	153 0.2×	273	6.6k
Bernard Asselain France	59	2.0k 1.4×	2.1k 1.6×	298 0.4×	147 0.2×	515 0.7×	323	11.0k
Steven G. DuBois United States	47	2.4k 1.7×	2.7k 2.1×	422 0.5×	358 0.5×	2.5k 3.5×	281	7.4k

Countries citing papers authored by John P. Perentesis

Since Specialization

Citations

This map shows the geographic impact of John P. Perentesis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Perentesis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Perentesis more than expected).

Fields of papers citing papers by John P. Perentesis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Perentesis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Perentesis. The network helps show where John P. Perentesis may publish in the future.

Co-authorship network of co-authors of John P. Perentesis

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Perentesis. A scholar is included among the top collaborators of John P. Perentesis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Perentesis. John P. Perentesis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Indelicato, Daniel J., Adrian Esterman, Arnold C. Paulino, et al.. (2025). Acute Toxicities of Proton Craniospinal Irradiation in Pediatric Medulloblastoma: A Pediatric Proton/Photon Consortium Registry (PPCR) Study. International Journal of Particle Therapy. 16. 100747–100747.

Indelicato, Daniel J., Arnold C. Paulino, Jae Young Lee, et al.. (2025). Assessing Acute and Long‐Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood & Cancer. 72(10). e31811–e31811. 1 indexed citations

Williams, Michael T., Samantha L. Regan, Anthony Mascia, et al.. (2025). Effects of whole brain proton irradiation at conventional or ultra-high dose rate (FLASH), in adult male Sprague Dawley rats. Scientific Reports. 15(1). 10602–10602.

Hassan, Aishlin, Kathleen Hueneman, Averil Ma, et al.. (2024). Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis. Nature Communications. 15(1). 9189–9189. 8 indexed citations

LeBlanc, Francis, Erin H. Breese, Karen Burns, et al.. (2024). Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British Journal of Haematology. 205(3). 1055–1066. 3 indexed citations

O’Brien, Eric, et al.. (2024). High-Throughput Drug Repurposing Identifies SN-38 As a Potent Inhibitor of AML with Synergistic Effects in Combination with PARP and BCL-2 Inhibitors for Treating KMT2A-Rearranged Leukemias. Blood. 144(Supplement 1). 2203–2203.

McGrady, Meghan E., Tyler G. Ketterl, Robin E. Norris, et al.. (2023). Barriers to medication adherence among adolescents and young adults with cancer. Pediatric Blood & Cancer. 70(3). 6 indexed citations

Rubinstein, Jeremy D., et al.. (2023). Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy. Pediatric Blood & Cancer. 70(4). e30214–e30214. 2 indexed citations

Daugherty, Emily, Anthony Mascia, Eunsin Lee, et al.. (2022). FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study. JMIR Research Protocols. 12. e41812–e41812. 60 indexed citations

10.

Hueneman, Kathleen, Lyndsey Bolanos, Kwangmin Choi, et al.. (2021). The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia. Leukemia. 36(2). 438–451. 25 indexed citations

11.

Ullrich, Nicole J., Sanjay P. Prabhu, Roger J. Packer, et al.. (2020). Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children. Pediatric Blood & Cancer. 68(4). e28833–e28833. 13 indexed citations

12.

Sertorio, Mathieu, et al.. (2020). Comparison of FLASH vs Conventional Dose Rate Proton Radiation in Endogenous Mouse Brain Tumor Model. International Journal of Radiation Oncology*Biology*Physics. 108(3). e742–e742. 4 indexed citations

13.

Meyer, Sara E., David E. Muench, Andrew M. Rogers, et al.. (2018). miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. The Journal of Experimental Medicine. 215(8). 2115–2136. 20 indexed citations

14.

Fouladi, Maryam, John P. Perentesis, Lars M. Wagner, et al.. (2014). A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report. Clinical Cancer Research. 21(7). 1558–1565. 16 indexed citations

15.

Patel, Ami V., David Eaves, Walter J. Jessen, et al.. (2012). Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target. Clinical Cancer Research. 18(18). 5020–5030. 47 indexed citations

16.

Johansson, Gunnar, Yonatan Y. Mahller, Margaret H. Collins, et al.. (2008). Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Molecular Cancer Therapeutics. 7(5). 1237–1245. 104 indexed citations

17.

Bhatla, Deepika, Robert B. Gerbing, Todd A. Alonzo, et al.. (2008). Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. British Journal of Haematology. 144(3). 388–394. 30 indexed citations

18.

Nagarajan, Rajaram, Brenda J. Weigel, Roby C. Thompson, & John P. Perentesis. (2003). Osteosarcoma in the first decade of life. Medical and Pediatric Oncology. 41(5). 480–483. 19 indexed citations

19.

Perentesis, John P. & Eric L. Sievers. (2001). Targeted Therapies for High-Risk Acute Myeloid Leukemia. Hematology/Oncology Clinics of North America. 15(4). 677–701. 5 indexed citations

20.

Perentesis, John P., et al.. (1997). Granulocyte-Macrophage colony-Stimulating factor receptor-Targeted therapy of chemotherapy- and radiation-Resistant human myeloid leukemias. Leukemia & lymphoma. 25(3-4). 247–256. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact